Corporate Member News

NCPDP Members Vote to Support the LexisNexis LexID, a Patient Identity Solution

The National Council for Prescription Drug Programs (NCPDP) members voted to support the LexisNexis® Risk Solutions LexID® as a universal patient identifier (UPI) at their recent workgroup meeting in November. This is an important step for the healthcare industry to address preventable errors by helping to ensure accurate identification of patients using a UPI. It assists in uniquely identifying each patient throughout disparate healthcare systems.  

Click for Full Release